The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
Learn how to license this index| Component | Country | Weight |
|---|---|---|
| GRAIL INC | US | 3.44% |
| ADAPTIVE BIOTECHNOLOGIES CORP | US | 2.84% |
| CARSGEN THERAPEUTICS HOLDING | KY | 2.84% |
| GUARDANT HEALTH INC | US | 2.28% |
| CUREVAC BV | NL | 2.15% |
| PHARMING GROUP NV | NL | 2.13% |
| ANAVEX LIFE SCIENCES CORP | US | 2.04% |
| BLUEPRINT MEDICINES CORP | US | 2.04% |
| GENSCRIPT BIOTECH CORP | KY | 2.03% |
| ALNYLAM PHARMACEUTICALS INC | US | 1.98% |
Gain access to all index Data and Services. Receive update on market developments, index news and corporate announcements.
Sign up nowAlready have an account? Log in here
Country weightings are based on the weightings of all index components in a certain country.
| Country | Components | Weight |
|---|---|---|
| Netherlands | 5 | 8.83% |
| United States | 54 | 73.10% |
| Cayman Islands | 3 | 6.60% |
| United Kingdom | 3 | 4.16% |
| Belgium | 1 | 1.82% |
| Japan | 1 | 1.63% |
| Germany | 1 | 1.55% |
| Switzerland | 1 | 1.48% |
| Singapore | 1 | 0.83% |
| Total | 70 | 100.00% |
Sector weightings are based on the weightings of all index components in a certain sector.
| Sector | Components | Weight |
|---|---|---|
| Health Care | 69 | 98.56% |
| Materials | 1 | 1.44% |
| Total | 70 | 100.00% |
| Size | Market Cap | Components | Weight |
|---|---|---|---|
| Large-Cap | 294,506,497,400 USD | 10 | 16.18% |
| Mid-Cap | 53,742,908,500 USD | 19 | 28.28% |
| Small-Cap | 21,378,121,110 USD | 35 | 51.18% |
| Micro-Cap | 844,601,700 USD | 6 | 4.37% |
| Total | 370,472,128,710 USD | 70 | 100.00% |
A license agreement is required to use MarketVector indexes, index data or trademarks for various commercial purpose. These include research and analysis, as well as the creation, introduction, promotion, or marketing of financial products such as exchange-traded products, mutual funds, certificates, derivatives, swaps, bonds, or OTC products connected to or derived from MarketVectorTM Indexes.
We can help you learn more about acquiring a suitable license for your needs.